+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Variability in the structure and expression of the aldose reductase gene modulates the risk for diabetic nephropathy



Variability in the structure and expression of the aldose reductase gene modulates the risk for diabetic nephropathy



Journal of the American Society of Nephrology 7(9): 1366




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034181879

Download citation: RISBibTeXText


Related references

The Z-2 microsatellite allele upregulates aldose reductase gene expression and increases the risk for diabetic nephropathy. Journal of the American Society of Nephrology 9(PROGRAM AND ABSTR ISSUE): 119A, Sept, 1997

Aldose reductase gene expression is increased in diabetic nephropathy. Journal of Clinical Endocrinology and Metabolism 82(7): 2294-2298, 1997

Diabetic nephropathy is not associated with the dinucleotide repeat polymorphism upstream of the aldose reductase (ALR2) gene but with erythrocyte aldose reductase content in Japanese subjects with type 2 diabetes. Diabetes 48(2): 420-422, 1999

Z-2 microsatellite allele is linked to increased expression of the aldose reductase gene in diabetic nephropathy. Journal of Clinical Endocrinology and Metabolism 83(8): 2886-2891, 1998

Is rs759853 polymorphism in promoter of aldose reductase gene a risk factor for diabetic nephropathy? A meta-analysis. European Journal of Medical Research 20(): 14-14, 2016

Aldose reductase gene variants are not associated with the risk of developing diabetic nephropathy even in the presence of poor glycemic control. Journal of the American Society of Nephrology 10(PROGRAM AND ABSTR ISSUE): 679A, Sept, 1999

Aldose reductase gene expression in peripheral blood mononuclear cells is increased in patients with diabetic nephropathy. Journal of the American Society of Nephrology 6(3): 455, 1995

Glucose transporter 5 and aldose reductase gene expression profiles and susceptibility to diabetic nephropathy in patients with type 1 diabetes. Diabetes 50(Supplement 2): A176, June, 2001

Aldose reductase gene expression may modulate risk for nephropathy in patients with type 1 diabetes. Journal of the American Society of Nephrology 5(3): 384, 1994

The C-106T polymorphism in promoter of aldose reductase gene is risk factor for diabetic nephropathy in type 2 diabetes patients with bad glycaemic control. Diabetologia 46(Supplement 2): A 333-A 334, August, 2003

C-106T polymorphism in promoter of aldose reductase gene is a risk factor for diabetic nephropathy in type 2 diabetes patients with poor glycaemic control. Nephron. Experimental Nephrology 99(3): E63-E67, 2005

Hyperglycaemic induction of aldose reductase mRNA in cells from patients with diabetic nephropathy is prevented by an inhibitor of aldose reductase. Diabetes 50(Supplement 2): A176, June, 2001

The 5'-end polymorphism of the aldose reductase gene is not associated with diabetic nephropathy in Caucasian type I diabetic patients. Diabetologia 42(8): 1030-1031, 1999

Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients. Diabetic Medicine 21(8): 867-873, 2004

Aldose reductase expression is induced by hyperglycemia in diabetic nephropathy. Kidney International 60(1): 211-218, 2001